1 / 7

Commercial (Non Government Sponsored) Health Plan Medical Cost and Premium Trends

Commercial (Non Government Sponsored) Health Plan Medical Cost and Premium Trends. Contribution to % Cost Medical Cost Medical Cost Trend Increase

zahur
Download Presentation

Commercial (Non Government Sponsored) Health Plan Medical Cost and Premium Trends

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Commercial (Non Government Sponsored)Health Plan Medical Costand Premium Trends Contribution to % Cost Medical Cost Medical Cost Trend Increase Component% of Medical Costs2002E2003E2005E2003E Pharmaceuticals 15% 14% 12% 11% 1.8% Hospital Inpatient 25 10 9 7 2.3 Outpatient 25 15 15 11 3.8 Physician 35 8 7 72.5 100% 11.2% 10.4% 8.5% 10.4% Premium Rate Increase 13-14% 13% 9.5% Source: Alliance Capital Management L.P. estimates

  2. U.S. Pharmaceutical Cost Trends (All Payors)1992-2005EAssumes No Medicare Drug Benefit Source: IMS Health and Alliance Capital Management L.P. estimates

  3. U.S. Pharmaceutical Market$ Sales Growth Source: IMS Health

  4. U.S. Pharmaceutical MarketDrug Price Inflation Year-to-year % change Source: IMS Health

  5. U.S. Pharmaceutical MarketPrescription Growth Year-to-year change Source: IMS Health

  6. GENERICS ARE GAINING TRACTION % Dollars % Total Prescriptions Dispensed Source: IMS Health

  7. US PHARMACEUTICAL MARKETPatent Expiration Exposure Worldwide Revenue for Products Off-Patent Years 2002-2006 Source: Merrill Lynch

More Related